D2R: A growing community with a shared vision

Earlier this month, over 150 researchers from across McGill and partner institutions came together at Le Centre Sheraton for the inaugural DNA to...
April 11, 2025

Inaugural Research Canada Innovates event at The Institute a resounding success

Sold-out event united health researchers and innovators to shape the future of healthcare On March 24, 2025, The Institute proudly partnered with Research...
April 11, 2025

What links cannabis use and psychosis? Researchers point to the brain’s dopamine system

‘Our findings could help doctors and mental health professionals better educate patients about the potential risks of frequent cannabis use’  A McGill University-led...
April 11, 2025

Epinephrine could reduce hospitalizations in pediatric intensive care after a severe allergic reaction

Research confirms the use of epinephrine before arrival at the hospital significantly reduces intensive care admissions for anaphylactic reactions During a severe allergic...
April 11, 2025

Experts from the McGill International TB Centre and The Institute publish a prestigious Lancet seminar on TB

Commissioned work underscores the role of tuberculosis (TB) as a leading cause of death globally, stressing the importance of early diagnosis, comprehensive care,...
April 11, 2025

McGill discovery sheds new light on autism, intellectual disabilities

Breakthrough that stands to rewrite the textbooks on brain function could lead to treatments A new study by McGill University researchers yields insights...
April 11, 2025

Julia Burnier: Engaging patients in research

Oncology researcher is building partnerships with cancer agencies to empower patients and transform research   As Program Director of the Global Oncology Program in...
April 11, 2025

Genetic sequencing project receives more than $8 million in funding

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians   A project led by Ziv Gan-Or, MD, PhD,...
April 3, 2025

Anti-swelling drug reduces immune response in brain cancer patients weeks after last dose

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy Swelling caused by brain cancer is a problem that can lead to...
April 2, 2025

GLP-1 diabetes drugs not linked to heightened suicidality risk

Despite previous concerns, findings provide reassurance about the psychiatric safety of these drugs, say researchers from the Lady Davis Institute for Medical Research...
April 2, 2025

Latest Alzheimer’s drug shown less effective in women

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi,...
April 2, 2025

COVID-19 boosters help avoid breakthrough infections in immunocompromised people, McGill-led study finds

Researchers focused on those with rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis and other immune-mediated inflammatory diseases New research findings provide solid...
April 2, 2025

AI analysis challenges autism diagnosis criteria

Researchers suggest behavioural traits are more telling than social communication and interaction factors, so diagnostic focus should be sharpened An analysis of digital...
April 2, 2025

Génome Québec and Cystic Fibrosis Canada invest $1.2 million in research tackling rare, orphan CFTR mutations

Génome Québec and Cystic Fibrosis Canada today announced a $1.2 million investment in two new research projects focused on rare genetic mutations that...
April 2, 2025